Cargando…
Late Aminophylline Reversal of Regadenoson Stress Testing in Patients with End Stage Renal Disease
Regadenoson is a widely used and well-tolerated vasodilator agent for pharmacologic stress myocardial perfusing imaging. In patients at higher risk of adverse reactions such as those with end stage renal disease, it can be reversed with early administration of aminophylline. However, little is known...
Autores principales: | Abudiab, Muaz M., Freiman, Samuel Unzek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4150159/ https://www.ncbi.nlm.nih.gov/pubmed/25191132 http://dx.doi.org/10.4103/1450-1147.139148 |
Ejemplares similares
-
Regadenoson Stress Testing: A Comprehensive Review With a Focused Update
por: Elkholy, Karim O, et al.
Publicado: (2021) -
Positive Regadenoson Stress Test in a Patient on Phentermine With Normal Coronaries
por: Sendil, Selin, et al.
Publicado: (2022) -
Aminophylline shortage and current recommendations for reversal of vasodilator stress: an ASNC information statement endorsed by SCMR
por: Abidov, Aiden, et al.
Publicado: (2018) -
Aminophylline shortage and current recommendations for reversal of vasodilator stress: An ASNC information statement endorsed by SCMR
por: Abidov, Aiden, et al.
Publicado: (2018) -
Differentiating scleroderma renal crisis from other causes of thrombotic microangiopathy in a postpartum patient
por: Abudiab, Muaz, et al.
Publicado: (2013)